Clinical Trials
3 trialsNCT00923130 2018-04-17
Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00182702 2013-03-25
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00030992 2012-08-20
BMS 247550 to Treat Kidney Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed